Gastrohepatic Disorders

Pegozafermin is an investigational glycoPEGylated analog of FGF21.

Discontinuation rate higher for those aged 18 to 24 years vsyounger age groups.

By simplifying the dosing regimen, the Company hopes to improve patient adherence and treatment outcomes.

The FDA and CDC greenlight updated COVID-19; prescription drug for dry eye disease now available; head-to-head study compares Skyrizi to Stelara for Crohn disease; the REMS program has been updated for IBS treatment Lotronex; and the FDA cracks down on companies selling unnaproved eye products.

Significant improvements seen in symptoms on days 28 and 56; no synergistic effect seen for combination treatment.

Resmetirom is an oral thyroid hormone receptor-β selective agonist.

Vedolizumab is currently available for administration as an IV infusion under the brand name Entyvio.

Risankizumab is an interleukin-23 antagonist; ustekinumab is an interleukin-12 and -23 antagonist.

Many medical malpractice cases survive or fail based upon the expert testimony regarding standard of care.

Health care professionals should be aware of these risks and select patients for treatment accordingly.

Benefit for incident CRC was duration-dependent, with significantly reduced risk after two or more years of use

Seladelpar is an oral, selective peroxisome proliferator-activated receptor delta agonist.

Positive airway pressure treatment itself associated with less wheezing.

RELiZORB is a digestive enzyme cartridge designed to hydrolyze fats contained in enteral formulas.

The application is supported by data from two phase 3 trials: an induction study, INSPIRE and a maintenance study, COMMAND.

Hepzato Kit is supplied with the Hepzato 5×5 Drug Pack and the HDS; it is expected to be available in the fourth quarter of 2023.

In the great majority of cases, the jury’s ultimate decision is in favor of the doctor.

In their statement, the GI specialists noted that they are familiar with safety issues regarding endoscopy in patients with gastroparesis.

Model performance improved with combination of radiological, clinical data.